Papers: 3 Dec 2012 - 10 Dec 2012 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick 2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation. Duncan GS, Brenner D, Tusche MW, Brüstle A, Knobbe CB, Elia AJ, Mock T, Bray MR, Krammer PH, Mak TW Proc Natl Acad Sci U S A. 2012 Dec 3. Epub 1969 Dec 31. PMID: 23213242. Abstract Editors' Pick Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data. Stellmann J-P, Neuhaus A, Herich L, Schippling S, Roeckel M, Daumer M, Martin R, Heesen C PLoS One. 2012; 7(11):e50347. Epub 2012 Nov 29. PMID: 23209717. Abstract Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study. Curley M, Josey L, Lucas R, Dear K, Taylor BV, Coulthard A, Ausimmune Investigator Group, Chapman C, Coulthard A, Dear K, et al. J Med Imaging Radiat Oncol. 2012 Dec; 56(6):594-8. PMID: 23210577. Abstract Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden. Bergvall N, Tambour M, Henriksson F, Fredrikson S J Med Econ. 2012 Dec 18. PMID: 23211038. Abstract Intractable Nausea and Vomiting from Autoantibodies Against a Brain Water Channel. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ Clin Gastroenterol Hepatol. 2012 Dec 1. PMID: 23211959. Abstract [An update on the treatment options for multiple sclerosis]. Niino M Brain Nerve. 2012 Dec; 64(12):1421-6. PMID: 23209069. Abstract Stretching the limbs? Tonic spasms in multiple sclerosis. Andrade C, Massano J, Guimarães J, Garrett M C BMJ Case Rep. 2012; 2012. PMID: 23208828. Abstract The relationship between muscle pain and fatigue. Mastaglia FL Neuromuscul Disord. 2012 Dec; 22 Suppl 3:S178-80. PMID: 23182635. Abstract Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS. Schad JN Med Hypotheses. 2012 Nov 30. PMID: 23207182. Abstract Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study. Lambrinoudaki I, Patikas E, Kaparos G, Armeni E, Rizos D, Thoda P, Alexandrou A, Antoniou A, Tsivgoulis G, Gatzonis S, et al. Neurol Sci. 2012 Dec 5. Epub 2012 Dec 05. PMID: 23212404. Abstract The detection of sensitivity of proprioception by a new clinical test: The dual joint position test. Beckmann Y Y, Ciftçi Y, Ertekin C Clin Neurol Neurosurg. 2012 Nov 30. PMID: 23206894. Abstract Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β Balasa R, Bajko Z, Hutanu A Mult Scler. 2012 Dec 3. PMID: 23207971. Abstract Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis. Bandari DS, Sternaman D, Chan T, Prostko CR, Sapir T J Manag Care Pharm. 2012 Dec; 18(9):1-17. PMID: 23206263. Abstract Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. Lunde HMB, Bjorvatn B, Myhr K-M, Bø L Acta Neurol Scand Suppl. 2013(196):24-30. PMID: 23190288. Abstract Optic nerve disease and axon pathophysiology. Ghaffarieh A, Levin LA Int Rev Neurobiol. 2012; 105:1-17. PMID: 23206593. Abstract Biomechanical disorders of foot in multiple sclerosis. Neamţu MC, Rusu L, Rusu PF, Marin M, Neamţu O M Rom J Morphol Embryol. 2012; 53(3 Suppl):841-5. PMID: 23188451. Abstract Humoral-Targeted Immunotherapies in Multiple Sclerosis. Lulu S, Waubant E Neurotherapeutics. 2012 Dec 4. PMID: 23208729. Abstract Fat-soluble vitamins as disease modulators in multiple sclerosis. Torkildsen O, Løken-Amsrud KI, Wergeland S, Myhr K-M, Holmøy T Acta Neurol Scand Suppl. 2013(196):16-23. PMID: 23190287. Abstract Multiple sclerosis: the role of cytokines in pathogenesis and in therapies. Amedei A, Prisco D, D'Elios M M Int J Mol Sci. 2012; 13(10):13438-60. PMID: 23202961. Abstract Olfactory memory impairment in neurodegenerative diseases. Bahuleyan B, Singh S J Clin Diagn Res. 2012 Oct; 6(8):1437-41. PMID: 23205370. Abstract Effect of high-dose vitamin d3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report. van Amerongen BM, Feron F Int J Mol Sci. 2012; 13(10):13461-83. PMID: 23202962. Abstract Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study. Goodin DS, Ebers GC, Cutter G, Cook SD, O'Donnell T, Reder AT, Kremenchutzky M, Oger J, Rametta M, Beckmann K, et al. BMJ Open. 2012; 2(6). PMID: 23204140. Abstract Tetracyclines and neuromuscular disorders. Orsucci D, Mancuso M, Filosto M, Siciliano G Curr Neuropharmacol. 2012 Jun; 10(2):134-8. PMID: 23204983. Abstract S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist. Cahalan SM, Gonzalez-Cabrera PJ, Nguyen N, Guerrero M, George Cisar EA, Leaf NB, Brown SJ, Roberts E, Rosen H Mol Pharmacol. 2012 Nov 30. PMID: 23204443. Abstract Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients. Reale M, de Angelis F, di Nicola M, Capello E, di Ioia M, De Luca G, Lugaresi A, Tata A M Int J Mol Sci. 2012; 13(10):12656-64. PMID: 23202919. Abstract Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T. Ozturk A, Aygun N, Smith SA, Caffo B, Calabresi PA, Reich DS Neuroradiology. 2012 Dec 4. Epub 2012 Dec 04. PMID: 23208410. Abstract MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis. Fenoglio C, Ridolfi E, Galimberti D, Scarpini E Int J Mol Sci. 2012; 13(10):13227-39. PMID: 23202949. Abstract Molecular pathogenesis of neuromyelitis optica. Bukhari W, Barnett MH, Prain K, Broadley SA Int J Mol Sci. 2012; 13(10):12970-93. PMID: 23202933. Abstract Interferon-β1b Increases Th2 Response in Neuromyelitis Optica. Nakajima H, Hosokawa T, Doi Y, Ikemoto T, Ishida S, Kimura F, Hanafusa T Int J Mol Sci. 2012; 13(10):12213-23. PMID: 23202893. Abstract Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations. González-Mendióroz M, Alvarez-Vázquez A B, Rubio-Martinez J J Mol Graph Model. 2012 Nov 17; 39C:13-22. PMID: 23202984. Abstract Developments in autoimmune channelopathies. Vincent A Autoimmun Rev. 2012 Nov 30. PMID: 23201922. Abstract Cannabinoid modulation of neuroinflammatory disorders. Saito VM, Rezende RM, Teixeira AL Curr Neuropharmacol. 2012 Jun; 10(2):159-66. PMID: 23204985. Abstract What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis? Buzzard KA, Broadley SA, Butzkueven H Int J Mol Sci. 2012; 13(10):12665-709. PMID: 23202920. Abstract Differential Regulation of CD4+ T Cell Adhesion to Cerebral Microvascular Endothelium by the β-Chemokines CCL2 and CCL3. Liu K K, Dorovini-Zis K Int J Mol Sci. 2012; 13(12):16119-40. PMID: 23203188. Abstract Experimental and therapeutic opportunities for stem cells in multiple sclerosis. Patani R, Chandran S Int J Mol Sci. 2012; 13(11):14470-91. PMID: 23203076. Abstract Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study. Denislic M, Milosevic Z, Zorc M, Ravnik ZID, Mendiz O Phlebology. 2012 Nov 30. PMID: 23202144. Abstract Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis. Dayger CA, Rosenberg JS, Winkler C, Foster S, Witkowski E, Benice TS, Sherman LS, Raber J Pharmacol Biochem Behav. 2012 Nov 30. PMID: 23201649. Abstract Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus. Mecha M, Carrillo-Salinas FJ, Mestre L, Feliú A, Guaza C Prog Neurobiol. 2012 Nov 29. PMID: 23201558. Abstract Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Costanza M, Colombo MP, Pedotti R Int J Mol Sci. 2012; 13(11):15107-25. PMID: 23203114. Abstract Early Growth Response Gene-2 Controls IL-17 Expression and Th17 Differentiation by Negatively Regulating Batf. Miao T, Raymond M, Bhullar P, Ghaffari E, Symonds ALJ, Meier UC, Giovannoni G, Li S, Wang P J Immunol. 2012 Nov 30. PMID: 23203924. Abstract [Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.] Haas J, Linker RA, Hartung HP, Meergans M, Ortler S, Tracik F Nervenarzt. 2012 Dec 2. PMID: 23203160. Abstract Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis. Yan J, Liu J, Lin C Y, Anzgene A N Z M S G C, Csurhes PA, Pender MP, McCombe PA, Greer JM Int J Mol Sci. 2012; 13(10):13667-79. PMID: 23202972. Abstract Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System? Jalilian B, Einarsson H B, Vorup-Jensen T Int J Mol Sci. 2012; 13(11):14579-605. PMID: 23203082. Abstract The role of neurotrophins in multiple sclerosis-pathological and clinical implications. Kalinowska-Lyszczarz A, Losy J Int J Mol Sci. 2012; 13(10):13713-25. PMID: 23202976. Abstract Ipsilateral uveitis and optic neuritis in multiple sclerosis. Thouvenot E, Mura F, De Verdal M, Carlander B, Charif M, Schneider C, Navarre S, Camu W Mult Scler Int. 2012; 2012:372361. Epub 2012 Nov 19. PMID: 23213530. Abstract Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology. Tardif CL, Bedell BJ, Eskildsen SF, Collins LD, Pike BG Mult Scler Int. 2012; 2012:742018. Epub 2012 Nov 18. PMID: 23213531. Abstract Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria. Alroughani R, Al Hashel J, Lamdhade S, Ahmed SF ISRN Neurol. 2012; 2012:792192. Epub 2012 Nov 01. PMID: 23209937. Abstract Effects of fatigue on balance and mobility in subjects with multiple sclerosis: a brief report. Gervasoni E, Cattaneo D, Montesano A, Jonsdottir J ISRN Neurol. 2012; 2012:316097. Epub 2012 Oct 31. PMID: 23209936. Abstract Post subthalamic area deep brain stimulation for tremors: a mini-review. Xie T, Bernard J, Warnke P Transl Neurodegener. 2012 Oct 29; 1(1):20. Epub 2012 Oct 29. PMID: 23210767. Abstract Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet? Josey L, Curley M, Jafari Mousavi F, Taylor BV, Lucas R, Coulthard A J Med Imaging Radiat Oncol. 2012 Dec; 56(6):588-93. Epub 2012 Sep 12. PMID: 23210576. Abstract Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases. Razavi S, Ahmadi N, Kazemi M, Mardani M, Esfandiari E Adv Biomed Res. 2012; 1:12. Epub 2012 May 11. PMID: 23210071. Abstract Ultrasonography in distinguishing optic neuritis from nonarteritic anterior ischemic optic neuropathy. Dehghani A, Giti M, Akhlaghi M R, Karami M, Salehi F Adv Biomed Res. 2012; 1:3. Epub 2012 Mar 28. PMID: 23210062. Abstract
Editors' Pick 2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation. Duncan GS, Brenner D, Tusche MW, Brüstle A, Knobbe CB, Elia AJ, Mock T, Bray MR, Krammer PH, Mak TW Proc Natl Acad Sci U S A. 2012 Dec 3. Epub 1969 Dec 31. PMID: 23213242. Abstract
Editors' Pick Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data. Stellmann J-P, Neuhaus A, Herich L, Schippling S, Roeckel M, Daumer M, Martin R, Heesen C PLoS One. 2012; 7(11):e50347. Epub 2012 Nov 29. PMID: 23209717. Abstract
Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study. Curley M, Josey L, Lucas R, Dear K, Taylor BV, Coulthard A, Ausimmune Investigator Group, Chapman C, Coulthard A, Dear K, et al. J Med Imaging Radiat Oncol. 2012 Dec; 56(6):594-8. PMID: 23210577. Abstract
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden. Bergvall N, Tambour M, Henriksson F, Fredrikson S J Med Econ. 2012 Dec 18. PMID: 23211038. Abstract
Intractable Nausea and Vomiting from Autoantibodies Against a Brain Water Channel. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, Pittock SJ Clin Gastroenterol Hepatol. 2012 Dec 1. PMID: 23211959. Abstract
[An update on the treatment options for multiple sclerosis]. Niino M Brain Nerve. 2012 Dec; 64(12):1421-6. PMID: 23209069. Abstract
Stretching the limbs? Tonic spasms in multiple sclerosis. Andrade C, Massano J, Guimarães J, Garrett M C BMJ Case Rep. 2012; 2012. PMID: 23208828. Abstract
The relationship between muscle pain and fatigue. Mastaglia FL Neuromuscul Disord. 2012 Dec; 22 Suppl 3:S178-80. PMID: 23182635. Abstract
Stress caused adverse entanglement of the nervous and autoimmune systems: A case for MS. Schad JN Med Hypotheses. 2012 Nov 30. PMID: 23207182. Abstract
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study. Lambrinoudaki I, Patikas E, Kaparos G, Armeni E, Rizos D, Thoda P, Alexandrou A, Antoniou A, Tsivgoulis G, Gatzonis S, et al. Neurol Sci. 2012 Dec 5. Epub 2012 Dec 05. PMID: 23212404. Abstract
The detection of sensitivity of proprioception by a new clinical test: The dual joint position test. Beckmann Y Y, Ciftçi Y, Ertekin C Clin Neurol Neurosurg. 2012 Nov 30. PMID: 23206894. Abstract
Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β Balasa R, Bajko Z, Hutanu A Mult Scler. 2012 Dec 3. PMID: 23207971. Abstract
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis. Bandari DS, Sternaman D, Chan T, Prostko CR, Sapir T J Manag Care Pharm. 2012 Dec; 18(9):1-17. PMID: 23206263. Abstract
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review. Lunde HMB, Bjorvatn B, Myhr K-M, Bø L Acta Neurol Scand Suppl. 2013(196):24-30. PMID: 23190288. Abstract
Optic nerve disease and axon pathophysiology. Ghaffarieh A, Levin LA Int Rev Neurobiol. 2012; 105:1-17. PMID: 23206593. Abstract
Biomechanical disorders of foot in multiple sclerosis. Neamţu MC, Rusu L, Rusu PF, Marin M, Neamţu O M Rom J Morphol Embryol. 2012; 53(3 Suppl):841-5. PMID: 23188451. Abstract
Humoral-Targeted Immunotherapies in Multiple Sclerosis. Lulu S, Waubant E Neurotherapeutics. 2012 Dec 4. PMID: 23208729. Abstract
Fat-soluble vitamins as disease modulators in multiple sclerosis. Torkildsen O, Løken-Amsrud KI, Wergeland S, Myhr K-M, Holmøy T Acta Neurol Scand Suppl. 2013(196):16-23. PMID: 23190287. Abstract
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies. Amedei A, Prisco D, D'Elios M M Int J Mol Sci. 2012; 13(10):13438-60. PMID: 23202961. Abstract
Olfactory memory impairment in neurodegenerative diseases. Bahuleyan B, Singh S J Clin Diagn Res. 2012 Oct; 6(8):1437-41. PMID: 23205370. Abstract
Effect of high-dose vitamin d3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report. van Amerongen BM, Feron F Int J Mol Sci. 2012; 13(10):13461-83. PMID: 23202962. Abstract
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study. Goodin DS, Ebers GC, Cutter G, Cook SD, O'Donnell T, Reder AT, Kremenchutzky M, Oger J, Rametta M, Beckmann K, et al. BMJ Open. 2012; 2(6). PMID: 23204140. Abstract
Tetracyclines and neuromuscular disorders. Orsucci D, Mancuso M, Filosto M, Siciliano G Curr Neuropharmacol. 2012 Jun; 10(2):134-8. PMID: 23204983. Abstract
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist. Cahalan SM, Gonzalez-Cabrera PJ, Nguyen N, Guerrero M, George Cisar EA, Leaf NB, Brown SJ, Roberts E, Rosen H Mol Pharmacol. 2012 Nov 30. PMID: 23204443. Abstract
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients. Reale M, de Angelis F, di Nicola M, Capello E, di Ioia M, De Luca G, Lugaresi A, Tata A M Int J Mol Sci. 2012; 13(10):12656-64. PMID: 23202919. Abstract
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T. Ozturk A, Aygun N, Smith SA, Caffo B, Calabresi PA, Reich DS Neuroradiology. 2012 Dec 4. Epub 2012 Dec 04. PMID: 23208410. Abstract
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis. Fenoglio C, Ridolfi E, Galimberti D, Scarpini E Int J Mol Sci. 2012; 13(10):13227-39. PMID: 23202949. Abstract
Molecular pathogenesis of neuromyelitis optica. Bukhari W, Barnett MH, Prain K, Broadley SA Int J Mol Sci. 2012; 13(10):12970-93. PMID: 23202933. Abstract
Interferon-β1b Increases Th2 Response in Neuromyelitis Optica. Nakajima H, Hosokawa T, Doi Y, Ikemoto T, Ishida S, Kimura F, Hanafusa T Int J Mol Sci. 2012; 13(10):12213-23. PMID: 23202893. Abstract
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations. González-Mendióroz M, Alvarez-Vázquez A B, Rubio-Martinez J J Mol Graph Model. 2012 Nov 17; 39C:13-22. PMID: 23202984. Abstract
Developments in autoimmune channelopathies. Vincent A Autoimmun Rev. 2012 Nov 30. PMID: 23201922. Abstract
Cannabinoid modulation of neuroinflammatory disorders. Saito VM, Rezende RM, Teixeira AL Curr Neuropharmacol. 2012 Jun; 10(2):159-66. PMID: 23204985. Abstract
What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis? Buzzard KA, Broadley SA, Butzkueven H Int J Mol Sci. 2012; 13(10):12665-709. PMID: 23202920. Abstract
Differential Regulation of CD4+ T Cell Adhesion to Cerebral Microvascular Endothelium by the β-Chemokines CCL2 and CCL3. Liu K K, Dorovini-Zis K Int J Mol Sci. 2012; 13(12):16119-40. PMID: 23203188. Abstract
Experimental and therapeutic opportunities for stem cells in multiple sclerosis. Patani R, Chandran S Int J Mol Sci. 2012; 13(11):14470-91. PMID: 23203076. Abstract
Disability caused by multiple sclerosis is associated with the number of extra cranial venous stenoses: possible improvement by venous angioplasty. Results of a prospective study. Denislic M, Milosevic Z, Zorc M, Ravnik ZID, Mendiz O Phlebology. 2012 Nov 30. PMID: 23202144. Abstract
Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis. Dayger CA, Rosenberg JS, Winkler C, Foster S, Witkowski E, Benice TS, Sherman LS, Raber J Pharmacol Biochem Behav. 2012 Nov 30. PMID: 23201649. Abstract
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus. Mecha M, Carrillo-Salinas FJ, Mestre L, Feliú A, Guaza C Prog Neurobiol. 2012 Nov 29. PMID: 23201558. Abstract
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Costanza M, Colombo MP, Pedotti R Int J Mol Sci. 2012; 13(11):15107-25. PMID: 23203114. Abstract
Early Growth Response Gene-2 Controls IL-17 Expression and Th17 Differentiation by Negatively Regulating Batf. Miao T, Raymond M, Bhullar P, Ghaffari E, Symonds ALJ, Meier UC, Giovannoni G, Li S, Wang P J Immunol. 2012 Nov 30. PMID: 23203924. Abstract
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.] Haas J, Linker RA, Hartung HP, Meergans M, Ortler S, Tracik F Nervenarzt. 2012 Dec 2. PMID: 23203160. Abstract
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis. Yan J, Liu J, Lin C Y, Anzgene A N Z M S G C, Csurhes PA, Pender MP, McCombe PA, Greer JM Int J Mol Sci. 2012; 13(10):13667-79. PMID: 23202972. Abstract
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System? Jalilian B, Einarsson H B, Vorup-Jensen T Int J Mol Sci. 2012; 13(11):14579-605. PMID: 23203082. Abstract
The role of neurotrophins in multiple sclerosis-pathological and clinical implications. Kalinowska-Lyszczarz A, Losy J Int J Mol Sci. 2012; 13(10):13713-25. PMID: 23202976. Abstract
Ipsilateral uveitis and optic neuritis in multiple sclerosis. Thouvenot E, Mura F, De Verdal M, Carlander B, Charif M, Schneider C, Navarre S, Camu W Mult Scler Int. 2012; 2012:372361. Epub 2012 Nov 19. PMID: 23213530. Abstract
Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology. Tardif CL, Bedell BJ, Eskildsen SF, Collins LD, Pike BG Mult Scler Int. 2012; 2012:742018. Epub 2012 Nov 18. PMID: 23213531. Abstract
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria. Alroughani R, Al Hashel J, Lamdhade S, Ahmed SF ISRN Neurol. 2012; 2012:792192. Epub 2012 Nov 01. PMID: 23209937. Abstract
Effects of fatigue on balance and mobility in subjects with multiple sclerosis: a brief report. Gervasoni E, Cattaneo D, Montesano A, Jonsdottir J ISRN Neurol. 2012; 2012:316097. Epub 2012 Oct 31. PMID: 23209936. Abstract
Post subthalamic area deep brain stimulation for tremors: a mini-review. Xie T, Bernard J, Warnke P Transl Neurodegener. 2012 Oct 29; 1(1):20. Epub 2012 Oct 29. PMID: 23210767. Abstract
Imaging and diagnostic criteria for Multiple Sclerosis: Are we there yet? Josey L, Curley M, Jafari Mousavi F, Taylor BV, Lucas R, Coulthard A J Med Imaging Radiat Oncol. 2012 Dec; 56(6):588-93. Epub 2012 Sep 12. PMID: 23210576. Abstract
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases. Razavi S, Ahmadi N, Kazemi M, Mardani M, Esfandiari E Adv Biomed Res. 2012; 1:12. Epub 2012 May 11. PMID: 23210071. Abstract
Ultrasonography in distinguishing optic neuritis from nonarteritic anterior ischemic optic neuropathy. Dehghani A, Giti M, Akhlaghi M R, Karami M, Salehi F Adv Biomed Res. 2012; 1:3. Epub 2012 Mar 28. PMID: 23210062. Abstract